Voya Investment Management LLC Has $246,000 Stock Holdings in LifeStance Health Group, Inc. $LFST

Voya Investment Management LLC trimmed its holdings in LifeStance Health Group, Inc. (NASDAQ:LFST) by 8.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,958 shares of the company’s stock after selling 3,488 shares during the quarter. Voya Investment Management LLC’s holdings in LifeStance Health Group were worth $246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. DekaBank Deutsche Girozentrale acquired a new position in shares of LifeStance Health Group in the 1st quarter valued at about $31,000. Xponance Inc. acquired a new position in LifeStance Health Group during the 1st quarter worth approximately $69,000. Ameriprise Financial Inc. acquired a new position in LifeStance Health Group during the 4th quarter worth approximately $87,000. Kapitalo Investimentos Ltda acquired a new position in LifeStance Health Group during the 1st quarter worth approximately $87,000. Finally, MQS Management LLC acquired a new position in LifeStance Health Group during the 1st quarter worth approximately $119,000. 85.50% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on LFST shares. Wall Street Zen raised LifeStance Health Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. UBS Group upped their price target on LifeStance Health Group from $8.50 to $9.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Finally, BTIG Research started coverage on LifeStance Health Group in a research note on Friday, July 25th. They set a “buy” rating and a $8.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Sell rating to the company. According to MarketBeat, LifeStance Health Group currently has an average rating of “Moderate Buy” and an average price target of $8.50.

Insiders Place Their Bets

In other LifeStance Health Group news, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the sale, the insider owned 14,324,197 shares in the company, valued at $72,623,678.79. This represents a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, major shareholder Summit Partners L. P sold 8,407,643 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $42,626,750.01. Following the sale, the insider owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This represents a 20.05% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 20,407,643 shares of company stock worth $103,466,750 over the last 90 days. Corporate insiders own 3.20% of the company’s stock.

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $5.42 on Tuesday. The stock has a fifty day simple moving average of $4.99 and a two-hundred day simple moving average of $5.56. LifeStance Health Group, Inc. has a 1-year low of $3.74 and a 1-year high of $8.61. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of -108.40 and a beta of 1.17. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Thursday, August 7th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.02. The business had revenue of $345.31 million during the quarter, compared to analyst estimates of $345.05 million. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.LifeStance Health Group’s revenue was up 10.6% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.06) earnings per share. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts anticipate that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.